Your browser doesn't support javascript.
loading
Ultrarapid lytic granule release from CTLs activates Ca2+-dependent synaptic resistance pathways in melanoma cells.
Filali, Liza; Puissegur, Marie-Pierre; Cortacero, Kevin; Cussat-Blanc, Sylvain; Khazen, Roxana; Van Acker, Nathalie; Frenois, François-Xavier; Abreu, Arnaud; Lamant, Laurence; Meyer, Nicolas; Vergier, Béatrice; Müller, Sabina; McKenzie, Brienne; Valitutti, Salvatore.
Affiliation
  • Filali L; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.
  • Puissegur MP; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.
  • Cortacero K; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.
  • Cussat-Blanc S; Institut de Recherche en Informatique de Toulouse (IRIT) - University Toulouse Capitole Centre national de la recherche scientifique (CNRS) UMR5505, Artificial and Natural Intelligence Toulouse Institute, Toulouse, France.
  • Khazen R; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.
  • Van Acker N; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.
  • Frenois FX; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.
  • Abreu A; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.
  • Lamant L; Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.
  • Meyer N; Department of Dermatology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.
  • Vergier B; Service de Pathologie, CHU de Bordeaux, Bordeaux, France.
  • Müller S; Equipe INSERM U1053-UMR BaRITOn (Eq 3), Université de Bordeaux, Bordeaux, France.
  • McKenzie B; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.
  • Valitutti S; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.
Sci Adv ; 8(7): eabk3234, 2022 02 18.
Article in En | MEDLINE | ID: mdl-35171665
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma / Antineoplastic Agents Limits: Humans Language: En Journal: Sci Adv Year: 2022 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma / Antineoplastic Agents Limits: Humans Language: En Journal: Sci Adv Year: 2022 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos